Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teijin to distribute Exogen system in Japan:

This article was originally published in Clinica

Executive Summary

Teijin is to begin distribution of Exogen's Sonic Accelerated Fracture Healing System (SAFHS) in Japan in June. The low intensity ultrasound device is approved in Japan for the healing of delayed and non-union bone fractures and Teijin has now received reimbursement approval from the Japanese Health and Welfare Ministry. The company, which has headquarters in Osaka and Tokyo, has paid a $400,000 milestone payment to Exogen. Piscataway, New Jersey-based Exogen's ultrasound and mechanical stress technologies are based on the principle that bone growth is stimulated by mechanical force.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT081468

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel